| 영문 | industrial health | 한글 | 산업보건 |
|---|---|---|---|
| 설명 | 기업체는 근로자의 생명과 건강에 대한 안전위생관리체제가 기업의 종류와 규모에 상응하게 의무화할 필요가 있다. 산업보건이란 이러한 노동위생문제의 개념을 더욱 폭넓게 확대하고 특히 근로자의 건강을 촉진시키고 재해를 예방한다거나 쾌적한 근로환경을 조성할 수 있도록 하는 것이다. |
||
| 영문 | alkylating agent | 한글 | 알킬화약물 |
|---|---|---|---|
| 설명 | 항암제의 일종. 이상적인 항암제는 정상적인 세포에는 해를 주지 않고 단지 암세포에만 치명적인 효과를 나타내야 한다. 이렇게 하려면 암세포만의 특이한 특성을 이해하고 그곳에만 작용하는 약물을 개발해야 한다. 현재 대부분의 항암제는 암세포가 정상 세포에 비하여 월등히 증식을 빨리한다는 특성을 이용하고 있다. 증식이 빠르다는 것은 다시 말하면 유전 정보를 가지고 있는 DNA의 복제가 빠르다는 것을 의미한다. 만약 DNA의 복제를 방해한다면 증식이 아주 빠른 암세포에게는 치명적이지만 영원히 증식을 하지 않는 DNA의 복제가 거의 필요없는)신경세포나 증식이 암세포에 비해서 아주 느린 정상세포에는 거의 영향을 주지 못한다. 하지만 신체에서도 증식이 암세포와 비슷한 수준으로 일어나는 정상적인 세포가 있는데 그것은 머리카락을 만드는 모낭세포와 소화관의 점막을 이루는 세포와 혈액의 세포를 만드는 골수 세포이다. 그러므로 항암제를 사용할 경우 암세포와 마찬가지로 이들 세포도 함께 치명적인 영향을 입을 것은 당연하다(그래서 항암제 치료시엔 머리가 빠지고 소화불량이 잘 온다). 알칼화약물의 경우에는 DNA와 직접 결합을 하여 DNA의 복제를 억제함으로써 항암제의 역할을 수행한다. |
||
| 영문 | anti-inflammatory agent | 한글 | 항염증제, 소염제, 염증약 |
|---|---|---|---|
| 설명 | 국소에 작용하여 염증을 치료하고 방지하는 약. 염증을 가라앉히는 약을 말한다. 조직을 긴축-치밀하게 하여 장액과 점액의 분비를 줄이고, 표면에 있는 작은 혈관에 빈혈을 일으켜 충혈되는 것을 방지함으로써 염증적 병변을 제거하여 모든 증세를 없앤다. 대부분의 수렴제-완화제-진양제가 이에 속한다. 중요한 성분으로는 알루미늄-비스무트-아연-납화합물(병반-페르마톨-아연화-연당 등) 등이 있다. 작용에 따라 항염증진통제와 항염증효소제로 나뉜다. |
||
| AHCA | Agency for Health Care Administration; American Health Care Association |
|---|---|
| HCPCS | Health Care Financing Administration common procedural collecting system; Health Care Financing Admi... |
| PHC | personal health costs; posthospital care; premolar hypodontia, hyperhidrosis, [premature] canities [... |
| HPA | Health Care Practice Act; Health Policy Agenda for the American People; health promotion advocates; ... |
| CCN | caudal central nucleus; community care network; coronary care nursing; critical care nursing |
| health care reform | Innovation and improvement of the health care system by reappraisal, amendment of services, and removal of faults and abuses in providing and distributing health services to patients. It includes a re-alignment of health services and health insurance to maximum demographic elements (the unemployed, indigent, uninsured, elderly, inner cities, rural areas) with reference to coverage, hospitalization, pricing and cost containment, insurers' and employers' costs, pre-existing medical conditions, prescribed drugs, equipment, and services. (12 Dec 1998) |
|---|---|
| health care sector | Economic sector concerned with the provision, distribution, and consumption of health care services and related products. (12 Dec 1998) |
| health care surveys | Statistical measures of utilization and other aspects of the provision of health care services including hospitalization and ambulatory care. (12 Dec 1998) |
| primary health care | Care which provides integrated, accessible health care services by clinicians who are accountable for addressing a large majority of personal health care needs, developing a sustained partnership with patients, and practicing in the context of family and community. (jama 1995;273(3):192) (12 Dec 1998) |
| proxy, health care | A health care proxy is one form of advance medical directive. Advance medical directives preserve the person's right to accept or reject a course of medical treatment even after that person becomes mentally or physically incapacitated to the point of being unable to communicate those wishes. There are two basic forms of advance directives: 1. A living will, in which the person outlines specific treatment guidelines that are to be followed by health care providers. 2. A health care proxy (also called a power of attorney for health-care decision-making) in which the person designates a trusted individual to make medical decisions in the event that he or she becomes too incapacitated to make such decisions. Advance directive requirements vary greatly from one jurisdiction to another and should therefore be drawn up in consultation with an attorney who is familiar with the laws of the particular jurisdiction. (this entry is based upon material from the national ms society). (12 Dec 1998) |
| national centre for health care technology | A centre in the public health service which coordinates and administers a program of research, demonstrations, and evaluations of medical technologies and assessments of health care technology. (12 Dec 1998) |
| delivery of health care | The concept concerned with all aspects of providing and distributing health services to a patient population. (12 Dec 1998) |
| delivery of health care, integrated | A health care system which combines physicians, hospitals, and other medical services with a health plan to provide the complete spectrum of medical care for its customers. In a fully integrated system, the three key elements - physicians, hospital, and health plan membership - are in balance in terms of matching medical resources with the needs of purchasers and patients. (coddington et al., integrated health care: reorganizing the physician, hospital and health plan relationship, 1994, p7) (12 Dec 1998) |
| quality assurance, health care | Activities and programs intended to assure or improve the quality of care in either a defined medical setting or a program. The concept includes the assessment or evaluation of the quality of care; identification of problems or shortcomings in the delivery of care; designing activities to overcome these deficiencies; and follow-up monitoring to ensure effectiveness of corrective steps. (12 Dec 1998) |
| quality indicators, health care | Norms, criteria, standards, and other direct qualitative and quantitative measures used in determinng the quality of health care. (12 Dec 1998) |
| quality of health care | The levels of excellence which characterise the health service or health care provided based on accepted standards of quality. (12 Dec 1998) |
| International Classification of Health Problems in Primary Care | A classification of diseases, conditions and problems arranged for use in primary care where diagnostic precision is seldom possible. (05 Mar 2000) |
| united states agency for health care policy and research | An agency of the public health service established in 1990 to "provide indexing, abstracting, translating, publishing, and other services leading to a more effective and timely dissemination of information on research, demonstration projects, and evaluations with respect to health care to public and private entities and individuals engaged in the improvement of health care delivery.." it supersedes the national centre for health services research. (12 Dec 1998) |
| united states health care financing administration | A component of the department of health and human services to oversee and direct the medicare and medicaid programs and related federal medical care quality control staffs. (12 Dec 1998) |
| adrenergic blocking agent | A compound that selectively blocks or inhibits responses to sympathetic adrenergic nerve activity (sympatholytic agent) and to epinephrine, norepinephrine, and other adrenergic amines (adrenolytic agent); two distinct classes exist, alpha-and beta-adrenergic receptor blocking agent's. (05 Mar 2000) |